Table 2.
Multiple regression analysis between the TIS total score and demographic and other clinical assessments.
| β | VIF | p value | |
|---|---|---|---|
| Age | 0.01 | 1.56 | 0.87 |
| Body height | −0.01 | 1.58 | 0.73 |
| Body weight | 0.02 | 1.11 | 0.58 |
| Duration of disease | 0.02 | 1.08 | 0.63 |
| Barthel index | 0.14 | 2.75 | 0.01** |
| Levodopa equivalent daily dose | 0.04 | 1.06 | 0.27 |
| MDS-UPDRS II 9 Turning in bed | −0.12 | 1.36 | 0.002** |
| MDS-UPDRS III total score | −0.08 | 2.75 | 0.14 |
| Hoehn and Yahr stage | −0.16 | 2.64 | 0.003** |
| Mini-BESTest total score | 0.27 | 4.06 | 0.00003*** |
| General lower extremity extension torque | 0.01 | 3.18 | 0.93 |
| Two-minute walk test | 0.05 | 2.60 | 0.35 |
| Handgrip force | 0.07 | 2.39 | 0.16 |
R2 = 0.52, p < 0.0001. *p < 0.05, **p < 0.01. β, standardized partial regression coefficient; VIF, variance inflation factor; R2, multiple coefficient of determination; MDS-UPDRS, movement disorders society-unified Parkinson’s disease rating scale; Mini-BESTest, Mini Balance Evaluation Systems Test; TIS, Trunk Impairment Scale.